HDAC5 tunes effector competence in differentiated human CD8+ T cells through an ACTL6A–IRF4 axis
Effective therapeutics for T cell-mediated autoimmune diseases must be capable of restraining pathogenic responses in both tissue-resident effector cells and circulating memory T cells while simultaneously preserving protective immunity. However, how these distinct, differentiated T cell populations calibrate their res...